Organ confined disease pathologic stage pt1 2 confers the best prognosis with 5 year cancer specific survival rates after nephrectomy ranging from 71 to 97.
Renal cell carcinoma survival after nephrectomy.
Adverse events were as anticipated in each group.
Renal cell carcinoma is the sixth most common cancer in the usa 1 where incidence rates have continued to rise in recent years 2 the prognosis of patients after a rcc diagnosis may follow an heterogeneous course on which the 5 year cancer specific survival rates may be as low as 38 in those patients with locally advanced or node positive disease 3 4.
Abstract background cytoreductive nephrectomy has been the standard of care in metastatic renal cell carcinoma for 20 years supported by randomized trials and large retrospective studies.
Bianchi m 1 becker a hansen j trinh qd tian z abdollah f briganti a shariat sf perrotte p montorsi f karakiewicz pi sun m.
Conditional survival after nephrectomy for renal cell carcinoma rcc.
Survival rates for renal cell carcinoma are sometimes based on the percentage.
No significant differences in response rate or progression free survival were observed.
The median overall survival was 18 4 months in the sunitinib alone group and 13 9 months in the nephrectomy sunitinib group.